Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin
GeroScience · 2024
DOI: 10.1007/s11357-024-01176-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift GeroScience, 2024. Verfasst von Richard A Miller und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Michigan, Ann Arbor, MI, USA. millerr@umich.edu. Hauptthemen laut MEDLINE: Canagliflozin, Thiosulfates, Longevity. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
Genetically heterogeneous UM-HET3 mice born in 2020 were used to test possible lifespan effects of alpha-ketoglutarate (AKG), 2,4-dinitrophenol (DNP), hydralazine (HYD), nebivolol (NEBI), 16α-hydroxyestriol (OH_Est), and sodium thiosulfate (THIO), and to evaluate the effects of canagliflozin (Cana) when started at 16 months of age. OH_Est produced a 15% increase (p = 0.0001) in median lifespan in males but led to a significant (7%) decline in female lifespan. Cana, started at 16 months, also led to a significant increase (14%, p = 0.004) in males and a significant decline (6%, p = 0.03) in females. Cana given to mice at 6 months led, as in our previous study, to an increase in male lifespan without any change in female lifespan, suggesting that this agent may lead to female-specific late-life harm. We found that blood levels of Cana were approximately 20-fold higher in aged females than in young males, suggesting a possible mechanism for the sex-specific disparities in its effects. NEBI was also found to produce a female-specific decline (4%, p = 0.03) in lifespan. None of the other tested drugs provided a lifespan benefit in either sex. These data bring to 7 the list of ITP-tested drugs that induce at least a 10% lifespan increase in one or both sexes, add a fourth drug with demonstrated mid-life benefits on lifespan, and provide a testable hypothesis that might explain the sexual dimorphism in lifespan effects of the SGLT2 inhibitor Cana.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Michigan, Ann Arbor, MI, USA. millerr@umich.edu.
- Geriatrics Center, University of Michigan, Ann Arbor, MI, USA. millerr@umich.edu.
- The Jackson Laboratory, Bar Harbor, ME, USA.
- Molecular Biosciences, University of California, Davis, CA, USA.
- Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Pharmacology, Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
ORCID-Profile: Richard A Miller
Förderung
- NIA NIH HHS
- NIH HHS
- National Institute on Aging
Zitieren
APA
Miller, R. A., Harrison, D. E., Cortopassi, G. A., Dehghan, I., Fernandez, E., Garratt, M., Geisler, J. G., Ginsburg, B. C., Han, M. L., Kaczorowski, C. C., Kumar, N., Leiser, S. F., Lopez-Cruzan, M., Milne, G., Mitchell, J. R., Nelson, J. F., Reifsnyder, P. C., Salmon, A. B., Korstanje, R., …, & Strong, R. (2024). Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin. GeroScience. https://doi.org/10.1007/s11357-024-01176-2
Vancouver
Miller RA, Harrison DE, Cortopassi GA, Dehghan I, Fernandez E, Garratt M, et al. Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin. GeroScience. 2024. doi:10.1007/s11357-024-01176-2
BibTeX
@article{Miller2024,
author = {Miller, Richard A and Harrison, David E and Cortopassi, Gino A and Dehghan, Ishmael and Fernandez, Elizabeth and Garratt, Michael and Geisler, John G and Ginsburg, Brett C and Han, Melissa L and Kaczorowski, Catherine C and Kumar, Navasuja and Leiser, Scott F and Lopez-Cruzan, Marisa and Milne, Ginger and Mitchell, James R and Nelson, James F and Reifsnyder, Peter C and Salmon, Adam B and Korstanje, Ron and Rosenthal, Nadia and Strong, Randy},
title = {Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin},
journal = {GeroScience},
year = {2024},
doi = {10.1007/s11357-024-01176-2}
}
EUVIMED